LeMaitre Vascular LMAT Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $26.85M-4.9% | $28.24M+10.8% | $25.49M-6.2% | $27.18M+7.2% | $25.34M-1.1% | ||
| $340.38M+2.9% | $330.88M+4.2% | $317.56M+8.6% | $292.31M+5.4% | $277.21M+1.1% | ||
| $35.77M+6.4% | $33.61M+3.7% | $32.42M-11.3% | $36.54M+4.1% | $35.11M+16.8% | ||
| $477.82M+2.0% | $468.23M+3.6% | $452.03M+5.1% | $430.13M+5.4% | $408.11M+1.5% | ||
| $28.54M+5.7% | $27M+2.0% | $26.46M+4.4% | $25.36M+1.0% | $25.11M+1.2% | ||
| $65.95M0.0% | $65.95M0.0% | $65.95M0.0% | $65.95M0.0% | $65.95M0.0% | ||
| $31.67M-4.3% | $33.09M+4.3% | $31.71M-4.3% | $33.15M-3.6% | $34.4M-4.0% | ||
| $629.53M+2.2% | $615.69M+2.9% | $598.07M+3.5% | $577.59M+3.9% | $556.01M+0.8% | ||
| $4.18M+14.6% | $3.65M+5.2% | $3.47M-29.5% | $4.91M+125% | $2.18M+23.9% | ||
| $33.37M-8.1% | $36.32M+9.1% | $33.29M+8.0% | $30.82M+24.5% | $24.75M-19.2% | ||
| $222.9M+0.3% | $222.17M+1.4% | $219.15M+2.0% | $214.91M+3.1% | $208.43M-2.8% | ||
| $245K+0.4% | $244K+0.4% | $243K+0.4% | $242K0.0% | $242K0.0% | ||
| $194.68M+5.4% | $184.72M+6.4% | $173.67M+8.0% | $160.84M+6.1% | $151.58M+4.5% | ||
| $406.62M+3.3% | $393.52M+3.9% | $378.92M+4.5% | $362.69M+4.3% | $347.57M+3.0% | ||
| $629.53M+2.2% | $615.69M+2.9% | $598.07M+3.5% | $577.59M+3.9% | $556.01M+0.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can LeMaitre Vascular cover its short-term obligations?
- Its current ratio is 14.32 — current assets exceed current liabilities.
- Where does LeMaitre Vascular's balance sheet data come from?
- Every line is extracted from LeMaitre Vascular's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.